Concepedia

Rose Mantel

RM

12

Publications

1.9K

Citations

11

H-Index

2014

Active since

Affiliations

The Ohio State University(Current)

The University of Texas MD Anderson Cancer Center

Arqule (United States)

National Student Clearinghouse Research Center

American Association of Colleges of Pharmacy

Rose Mantel is an author at The Ohio State University specializing in immunology, immunotherapy, and oncology.

Top concepts

Publications per year

2014–2019

12

Publications

12

Etiology of Ibrutinib Therapy Discontinuation and Outcomes in Patients With Chronic Lymphocytic Leukemia

Kami J. Maddocks, Amy S. Ruppert, Gerard Lozanski et al. · JAMA Oncology · 2015 · 568 citations · Full text

<i>BTK</i><sup>C481S</sup>-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia

Jennifer A. Woyach, Amy S. Ruppert, Daphne Guinn et al. · Journal of Clinical Oncology · 2017 · 461 citations · Full text

, , +14

Prolonged lymphocytosis during ibrutinib therapy is associated with distinct molecular characteristics and does not indicate a suboptimal response to therapy

Jennifer A. Woyach, Kelly A. Smucker, Lisa L. Smith et al. · Blood · 2014 · 273 citations · Full text

The BTK Inhibitor ARQ 531 Targets Ibrutinib-Resistant CLL and Richter Transformation

Sean D. Reiff, Rose Mantel, Lisa L. Smith et al. · Cancer Discovery · 2018 · 161 citations · Full text

The Bruton Tyrosine Kinase (BTK) Inhibitor Acalabrutinib Demonstrates Potent On-Target Effects and Efficacy in Two Mouse Models of Chronic Lymphocytic Leukemia

Sarah E. M. Herman, Arnau Montraveta, Carsten Utoft Niemann et al. · Clinical Cancer Research · 2016 · 157 citations · Full text

Rows per page

1–5 of 12